Pandemic Timeline

University of California, Rensselaer Polytechnic, DARPA file patent US7427497: In vitro metabolic engineering on microscale devices

Disclosed herein is a microfluidics device that can be used to prepare natural products and their analogs. The device comprises the enzymes of a biosynthetic pathway immobilized thereon and a means for sequentially directing a starting material and each ensuing reaction product to the enzymes of the biosynthetic pathway in the order corresponding to the steps of the biosynthetic pathway. The device can thus be used to prepare the natural product using the natural starting material of the biosynthetic pathway or analogs of the natural product using an unnatural starting material. Alternatively, artificial pathways can be created by immobilizing an appropriate selection of enzymes on the device in an order whereby each subsequent enzyme can catalyze a reaction with the product of the prior enzyme. Novel chemical entities can be prepared from these artificial pathways.

Patent US7427497B2

Source:

  • Patent
    September 23, 2008. Jonathan S. Dordick, Aravind Srinivasan, Jungbae Kim, David H. Sherman, and Douglas S. Clark. In vitro metabolic engineering on microscale devices. United States US7427497B2, filed November 1, 2002, and issued September 23, 2008. Assignee: University of California, University of Minnesota, Rensselaer Polytechnic Institute, Defense Advanced Research Projects Agency DARPA.
    https://patents.google.com/patent/US7427497B2,
    Local copy.
    Patent.

Comments are closed.